Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
NephroDI Therapeutics
Small molecule for concentration disorders of the kidney
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 22 Sep, 2023
"update inverses"
Golden AI
edited on 22 Sep, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Competitors
Macromoltek
Edits on 27 Jun, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 27 Jun, 2023
Infobox
SBIR/STTR Awards
NephroDI Therapeutics, Inc. STTR Phase I Award, September 2020
0
Edits on 18 Oct, 2022
Andrey Duzenko
edited on 18 Oct, 2022
Edits made to:
Infobox
(
+5
properties)
Infobox
CEO
Rachael Hagan
0
Founder
Jeff M. Sands
0
Janet D. Klein
0
Ish Khanna
0
Ram Pillarisetti
0
"update inverses"
Golden AI
edited on 18 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Investors
Xontogeny
0
Edits on 19 Sep, 2022
"prospector:1906:1372022"
Katrina-Kay Pettitt
edited on 19 Sep, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Engineering
Edits on 24 Jul, 2022
Seotaek Lee
edited on 24 Jul, 2022
Edits made to:
Infobox
(
+2
properties)
Infobox
Crunchbase URL
https://www.crunchbase.com/organization/nephrodi-therapeutics
Pitchbook URL
https://pitchbook.com/profiles/company/461898-37
Edits on 22 Jul, 2022
"clean up phone number value"
Golden AI
edited on 22 Jul, 2022
Edits made to:
Infobox
(
+1
/
-1
properties)
Infobox
Phone number
206-696-0546
Phone number
+12066960546
Edits on 12 Jun, 2022
"Entity importer update"
Golden AI
edited on 12 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Is a
Organization
Edits on 8 Apr, 2022
"Patent autocalculation"
Golden AI
edited on 8 Apr, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents assigned (count)
1
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-1
properties)
Infobox
Patents
US Patent 11179354 Substituted cycloalkanes for managing nephrogenic diabetes insipidus
Edits on 25 Nov, 2021
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patents
US Patent 11179354 Substituted cycloalkanes for managing nephrogenic diabetes insipidus
Edits on 29 Jul, 2021
Golden AI
edited on 29 Jul, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
SBA Awards
NephroDI Therapeutics, Inc. STTR Phase I Award, September 2020
Edits on 14 Jun, 2021
"prospector:330:162028"
Erin Scherfner
edited on 14 Jun, 2021
Edits made to:
Infobox
(
+2
properties)
Description
(
+56
characters)
NephroDI Therapeutics
Small molecule for concentration disorders of the kidney
Infobox
Country
United States
Industry
Biomedical engineering
Edits on 13 May, 2021
Aime Anne Nisay
edited on 13 May, 2021
Edits made to:
Infobox
(
+4
properties)
Timeline
(
+1
events)
(
+71
characters)
NephroDI Therapeutics
Small molecule for concentration disorders of the kidney
Infobox
Legal name
NephroDI Therapeutics, Inc.
Company status
Active
LinkedIn
https://www.linkedin.com/company/nephrodi-therapeutics-inc
Phone number
206-696-0546
Timeline
May 12, 2021
NephroDI Therapeutics, Inc. announces a seed investment from Xontogeny
.
"Initial creation data"
Aime Anne Nisay
edited on 13 May, 2021
Edits made to:
Infobox
(
+2
properties)
Infobox
Is a
Company
Website
http://nephrodi.com/
"Created via: Web app"
Aime Anne Nisay
created this topic on 13 May, 2021
Edits made to:
NephroDI Therapeutics
Small molecule for concentration disorders of the kidney
Find more companies like NephroDI Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE